Literature DB >> 7849253

Endogenous dopamine regulates phosphate reabsorption but not NaK-ATPase in spontaneously hypertensive rat kidneys.

A Debska-Slizien1, P Ho, R Drangova, A D Baines.   

Abstract

Dopamine's modulatory actions on signal transduction in the spontaneously hypertensive rat (SHR) proximal tubule are blunted; therefore, it was predicted that dopamine does not regulate phosphate (Pi) reabsorption in SHR. To test this hypothesis, dopamine production was inhibited with carbidopa (10 mg/kg ip) 18 h before and during clearance measurements of chronically denervated SHR and Wistar-Kyoto (WKY) rat kidneys. Dopamine excretion decreased 80% from SHR and 85% from WKY rats. Pi excretion decreased 60 to 67%. Plasma Pi and calcium, inulin clearance, and Na excretion did not change. Citrate excretion, which reflects proton secretion by proximal tubules, decreased 72% from WKY rats. Citrate excretion was significantly lower from SHR (5 +/- 10 pmol/min) than from WKY rats (73 +/- 11 pmol/min) and was not altered by carbidopa. Carbidopa, injected 18 and 1 h before kidneys were collected, increased NaK-ATPase in cortical basolateral membranes from WKY rats (27%) but not in membranes from SHR. After the incubation of renal cortical minceates for 15 min with L-DOPA (10(-5) M), there was no change in brush border membrane vesicle uptake of 32Pi, (3H)glucose, or (14C)citrate. Incubation with carbidopa (10(-4) M) increased 32Pi uptake by 11% (P < 0.001) and (3H)glucose uptake by 9% (P = 0.02). (14C)citrate uptake was not increased by carbidopa but was higher in SHR (977 +/- 2 pmol/10 s.mg) than in WKY rats (823 +/- 43 pmol/10 s.mg; P = 0.04). In summary, dopamine produced in WKY rat and SHR proximal tubules decreases Pi uptake by using a signaling process distinct from those that regulate NaK-ATPase and the antiporter.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7849253     DOI: 10.1681/ASN.V541125

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  6 in total

Review 1.  Dopamine, the kidney, and hypertension.

Authors:  Raymond C Harris; Ming-Zhi Zhang
Journal:  Curr Hypertens Rep       Date:  2012-04       Impact factor: 5.369

Review 2.  Dopamine receptor-coupling defect in hypertension.

Authors:  Pedro A Jose; Gilbert M Eisner; Robin A Felder
Journal:  Curr Hypertens Rep       Date:  2002-06       Impact factor: 5.369

Review 3.  Abnormalities in renal dopamine signaling and hypertension: the role of GRK4.

Authors:  Raymond C Harris
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-01       Impact factor: 2.894

4.  G protein-coupled receptor kinase 4 gene variants in human essential hypertension.

Authors:  Robin A Felder; Hironobu Sanada; Jing Xu; Pei-Ying Yu; Zheng Wang; Hidetsuna Watanabe; Laureano D Asico; Wei Wang; Shaopeng Zheng; Ikuyo Yamaguchi; Scott M Williams; James Gainer; Nancy J Brown; Debra Hazen-Martin; Lee-Jun C Wong; Jean E Robillard; Robert M Carey; Gilbert M Eisner; Pedro A Jose
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

5.  Caveolin-1 and dopamine-mediated internalization of NaKATPase in human renal proximal tubule cells.

Authors:  John J Gildea; Jonathan A Israel; Andrew K Johnson; Jin Zhang; Pedro A Jose; Robin A Felder
Journal:  Hypertension       Date:  2009-09-14       Impact factor: 10.190

6.  Relationship of urine dopamine with phosphorus homeostasis in humans: the heart and soul study.

Authors:  Nisha Bansal; Chi-Yuan Hsu; Mary Whooley; Anders H Berg; Joachim H Ix
Journal:  Am J Nephrol       Date:  2012-05-09       Impact factor: 3.754

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.